Gin Hwa Biotech Incorporation (TPEX:7806)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
60.90
0.00 (0.00%)
At close: Sep 2, 2026

TPEX:7806 Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
1,9351,7731,778
Market Cap Growth
21.05%-0.27%-
Last Close Price
60.0069.6267.89

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
PE Ratio
28.8923.5326.63
PS Ratio
3.613.294.09
PB Ratio
2.502.293.76
P/TBV Ratio
2.522.323.84
P/OCF Ratio
15.2122.5025.21

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Debt / Equity Ratio
0.210.280.38
Debt / EBITDA Ratio
1.541.641.62
Net Debt / Equity Ratio
0.110.120.14
Net Debt / EBITDA Ratio
0.820.740.58
Net Debt / FCF Ratio
-0.46-0.41-1.60
Asset Turnover
-0.58-
Inventory Turnover
-4.37-
Quick Ratio
0.911.561.98
Current Ratio
1.782.562.77
Return on Equity (ROE)
-12.09%-
Return on Assets (ROA)
-6.15%-
Return on Invested Capital (ROIC)
6.00%10.33%12.79%
Return on Capital Employed (ROCE)
7.20%9.80%13.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Earnings Yield
2.88%4.25%3.75%
FCF Yield
-9.72%-13.24%-2.29%
Payout Ratio
42.84%31.67%11.16%
Buyback Yield / Dilution
--11.74%-